A multiple sclerosis diagnosis used to mean a future of disability. But now, a revolution in medications allows MS patients to pursue their dreams.

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

The FDA approved use of the Atalante X robotic exoskeleton, which allows people with mobility issues to stand upright, for MS ...

Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

Discover how CAR T cell therapy is breaking new ground in treating Multiple Sclerosis for the first time in the UK ...

The Accelerated Cure for Multiple Sclerosis, a nonprofit that advocates for multiple sclerosis research, has launched a platform for patients to upload their own data and submit research questions ...

Roche's experimental multiple sclerosis drug achieved its main goal in one of two key late-stage trials testing it against ...

Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 readouts ...

A small cohort of individuals diagnosed with MS early in life had a significant employment-related impact that was associated ...

Case Western University scientists were gifted $2.5 million to advance MS research into whether glial cells can be targeted to repair myelin.

A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple ...

Sepsis is an alarmingly common cause behind ICU admissions in patients with multiple sclerosis (MS), a retrospective, population-based cohort study indicates. Furthermore, it contributes to a ...